You just read:

Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma

News provided by

Pharmacyclics, Inc.

Jun 16, 2013, 06:00 ET